Founders of companies often clash with CEOs hired to operate the business. But at Miromatrix Medical Inc., a regenerative medicine firm spun out of the University of Minnesota, it happened just over a year after the company began operations.
The company was spun out of UMinn in December 2009 and formally set up in February 2010 when the university signed an exclusive licensing agreement allowing the research of Doris Taylor to be commercialized.
